Gaetan Duport: A New Legislation for Medicines in Europe
Gaetan Duport, Economic and Public Health Committee (CEESP), user representative at Haute Autorité de Santé, reposted from EU Health and Food Safety on LinkedIn:
”A new step forward with the pharma package : a new legislation for medicines in Europe.
A key milestone for better access to treatement.”
Quoting EU Health and Food Safety‘s post:
”Major reform of EU pharmaceutical rules agreed!
We welcome the political agreement reached on the pharma reform last night, which is a crucial step in boosting innovation and investment in the EU’s pharma sector.
The main aim of the new rules is to make sure that medicines in the EU are safe, effective and available to all patients in Europe.
Amongst other things, the rules will:
- Expand access and availability of medicines
- Accelerate medicine supply chains – by cutting red pate for companies and reducing evaluation times for new medicines by the EMA.
- Place the EU at the forefront of pharmaceutical innovation – by offering world-leading incentives for innovative products.
- Allow for speedy market access for generic medicines
- Address medicine shortages
The new rules are complemented by the Critical Medicines’ Act proposal, the recent Life Sciences Strategy and the upcoming Biotech Act.
Check out the factsheet below for more information about the key elements of the reform
For more information.”
Stay updated with Hemostasis Today.
-
Dec 14, 2025, 16:06Dr Abdul Mannan: What’s Your Approach to Diagnosing Iron Deficiency in Tricky Cases?
-
Dec 14, 2025, 16:05Mark Young – 46 Shadow Gates: How Your Chromosomes Archive Ancestral Memory
-
Dec 14, 2025, 16:04NNHF Unveiled at ASH2025: a Bold New Chapter was Marked – Expanding Beyond Haemophilia Care to Include SCD and Thalassemia
-
Dec 14, 2025, 15:46Heghine Khachatryan about PVCS as Cause of Chronic Pelvic Pain and Lower-Extremity/Pelvic Varices in Women
-
Dec 14, 2025, 15:42Gianluca Franceschini – Prevention is the Future: Investing Today to Save Lives Tomorrow
-
Dec 14, 2025, 13:55Indunil Karunarathna: Anticoagulation Therapy in Atrial Fibrillation Risks and Benefits
-
Dec 14, 2025, 12:56Mentored by Riten Kumar, Sriveda Boyalakuntla Presents Key Research on Infection-Associated Thrombosis at ASH25
-
Dec 14, 2025, 12:54Paul Roscoe: Deeply Proud of the Mend Care Team in This Intervention
-
Dec 13, 2025, 20:23Wolfgang Miesbach: From Daily Pills to Remission after Short‑Course Therapy in ITP